Navigation Links
Covanta Announces Amended Terms for its Acquisition of Two Biomass Energy Facilities in Maine
Date:11/13/2008

ovanta's 38 Energy-from-Waste facilities provide communities with an environmentally sound solution to their solid waste disposal needs by using that municipal solid waste to generate clean, renewable energy. Annually, Covanta's modern Energy-from-Waste facilities safely and securely convert approximately 16 million tons of waste into more than 8 million megawatt hours of clean renewable electricity and create 10 billion pounds of steam that are sold to a variety of industries. For more information, visit http://www.covantaholding.com.

Cautionary Note Regarding Forward-Looking Statements Certain statements in this press release may constitute "forward-looking" statements as defined in Section 27A of the Securities Act of 1933 (the "Securities Act"), Section 21E of the Securities Exchange Act of 1934 (the "Exchange Act"), the Private Securities Litigation Reform Act of 1995 (the "PSLRA") or in releases made by the Securities and Exchange Commission ("SEC"), all as may be amended from time to time. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause the actual results, performance or achievements of Covanta and its subsidiaries, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Statements that are not historical fact are forward-looking statements. Forward-looking statements can be identified by, among other things, the use of forward-looking language, such as the words "plan," "believe," "expect," "anticipate," "intend," "estimate," "project," "may," "will," "would," "could," "should," "seeks," or "scheduled to," or other similar words, or the negative of these terms or other variations of these terms or comparable language, or by discussion of strategy or intentions. These cautionary statements are being made pursuant to the Securi
'/>"/>

SOURCE Covanta Holding Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Posit Science(R) Corporation Announces the Release of InSight(TM) 1.1
2. MedImmune Announces Zook as President
3. Yongye Biotechnology Announces Record Third Quarter Results
4. Human Pheromone Sciences Announces Third Quarter Results
5. WuXi PharmaTech Announces Third Quarter 2008 Results
6. Telik Announces New TRAP Drug Discovery Agreement
7. SciQuest Announces Strategic Alliance with QIAGEN
8. Spectral announces third quarter 2008 results
9. AMDL Announces Preliminary Third Quarter Earnings; Revises 2008 Guidance
10. Metabolex Announces Positive Results From Phase 1a Clinical Trial of MBX-2982
11. Standard & Poors Announces Changes to U.S. Indices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , Mar. 03, 2015 Research and Markets ... addition of Jain PharmaBiotech,s new report "Gene ... their offering. , Gene therapy ... nonviral vectors and cell therapy with genetically modified ... drug delivery and various routes of administration as ...
(Date:3/3/2015)... 2015 Elsevier,s DirectCourse online ... competency-based training to comply with new CMS requirements ... a new crosswalk tool to help providers ... for direct service workers as a means to comply ... regulations. CMS amended the regulations, effective March ...
(Date:3/3/2015)... March 3, 2015  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... with a focus on protecting the microbiome, announced today that ... present at the 27th Annual ROTH Conference being held on ... in Dana Point, CA. ... 2015 at 1:00 p.m. (Pacific Time). A live ...
(Date:3/3/2015)... 2015  PDL BioPharma, Inc. (PDL or the Company) ... third of three shareholder lawsuits filed in the fall ... On February 2, 2015, a securities lawsuit that was ... a putative class of purchasers of the Company,s stock, ... (D. Nev.), was voluntarily dismissed without prejudice.  Shortly thereafter, ...
Breaking Biology Technology:Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 2Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 3Elsevier's DirectCourse Can Help States Meet and Exceed New CMS Requirements for Home and Community-Based Services 2Elsevier's DirectCourse Can Help States Meet and Exceed New CMS Requirements for Home and Community-Based Services 3Synthetic Biologics to Present at the 27th Annual ROTH Conference 2PDL BioPharma Announces Dismissal of Third and Final Shareholder Lawsuit 2
... Based on its recent analysis of the ... Carl Zeiss Meditec with the 2009 North American ... optical coherence tomography (OCT) technology for ophthalmic applications. ... technology and has launched clinical tools that revolutionized ...
... March 31 For the first time, scientists have ... embryo) may be a potential new source of stem ... on February 12, 2009, in Blood , the ... on observations made by other scientists, our research team ...
... ArunA Biomedical, Inc., a leader in human embryonic ... co-developed a validated kit to produce induced pluripotent stem ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080819/CLTU003LOGO ... Open Biosystems will launch the complete and fully validated ...
Cached Biology Technology:Frost & Sullivan Lauds Carl Zeiss Meditec for Dominating the OCT Market for Ophthalmic Applications 2Frost & Sullivan Lauds Carl Zeiss Meditec for Dominating the OCT Market for Ophthalmic Applications 3Frost & Sullivan Lauds Carl Zeiss Meditec for Dominating the OCT Market for Ophthalmic Applications 4Amniotic Fluid May Provide New Source of Stem Cells for Future Therapies 2Amniotic Fluid May Provide New Source of Stem Cells for Future Therapies 3ArunA Biomedical Announces Co-development of Fully Validated Induced Pluripotent Stem Cell Kit 2
(Date:2/11/2015)... February 11, 2015 ... "Access Control Market by Product (Cards and Readers, Biometrics, ... Defense, Government, Industrial, Healthcare, Education) and By Geography - Global ... MarketsandMarkets, the Access Control Market is expected ... at a CAGR of 10.6% between 2014 ...
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America recently ... for carbon nanotube (CNT) macrostructures, including sheets, yarns and ... (UTD). Leveraging the vast industrial resources of ... Japan , Lintec of America is forming the ... TX , focusing on scaling up the manufacturing ...
(Date:2/5/2015)... RESEARCH TRIANGLE PARK, N.C. , Feb. 5, 2015 ... as a specialist logistics company and has launched a ... industry,s only Clinical Logistics Organization (CLO).  The new campaign ... with emphasis on patient, protocol and shipments. ... Patient First , aligns Marken,s priorities with its ...
Breaking Biology News(10 mins):Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marken Launches New Patient-Centric Campaign 2
... Every week in his clinic at the University of ... are dying or shrinking due to disease or injury. ... the other effects that nerve-destroying conditions cause and wishes ... or regenerate their nerves. Then he heads to his research ...
... stem cells derived from patients, own bone marrow either three ... does not improve heart function six months later, according to ... (NIH). The results of the trial, called Transplantation ... LateTIME, which found that such cells (called autologous stem cells) ...
... rocks and fossils, seems far removed from the world ... Whereas paleontology strives to determine "What happened in evolution?", ... to answer "How did it happen?" Combined, the two ... fields. In the current issue of the ...
Cached Biology News:Stem cells + nanofibers = Promising nerve research 2Stem cells + nanofibers = Promising nerve research 3Bone marrow stem cells do not improve short-term recovery after heart attack 2Bone marrow stem cells do not improve short-term recovery after heart attack 3Recent studies bring fossils and genes together to piece together evolutionary history 2Recent studies bring fossils and genes together to piece together evolutionary history 3
Mouse IL-31 RA Biotinylated Affinity Purified PAb...
Sf21 cells derived from Spodoptera frugiperda ovarian cells are recommended for high-level production of recombinant proteins. Higher expression levels of some proteins are seen due to the larger ce...
... consists of universal lysis buffer, PCR mix, ... 100 25 l volume PCR reactions. This ... negative or positive rod and coccus bacteria, ... Cereus, Staphylococcus Aureus, Streptococcus Agalactiae, and etc. ...
...
Biology Products: